Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Sympathetic Drive Control With Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction

NCT07293832 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT07293832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07293832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Sympathetic Drive Control With Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Observational
Overall status
Recruiting
Start date
November 13, 2024
Completion date
August 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stemi